EBMT 2023 | Update on the projects of the GoCART coalition
Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses the GoCART coalition’s progress in fostering development and access to CAR-T therapies and immune effector cell therapies, explaining how the coalition has made practical progress in advocacy and regulatory development. The coalition has published two papers on conditions for apheresis and product storage/distribution and is supporting various scientific projects that are using the EBMT registry. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
BELLICUM PHARMACEUTICALS: Membership on an entity’s Board of Directors or advisory committees BMS/CELGENE: Speakers Bureau, Membership on an entity’s Board of Directors or advisory committees EBMT: Membership on an entity’s Board of Directors or advisory committees FRESENIUS KABI: Research Funding KITE/GILEAD: Honoraria, Speakers Bureau, Membership on an entity’s Board of Directors or advisory committees JANSSEN PHARMACEUTICALS: Membership on an entity’s Board of Directors or advisory committees JAZZ: Honoraria MILTENYI BIOTECH: Research Funding NOVARTIS: Speakers Bureau SANOFI SA: Speakers Bureau, Honoraria, Research Funding TERUMO BCT: Speakers Bureau
